The PDCD4/miR-21 pathway in medullary thyroid carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Programmed cell death 4 (PDCD4) acts as a tumor suppressor, targeted by microRNA-21 (miR-21).
• PDCD4 regulation also involves the Akt pathway, a key player in cell survival.
• Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor where stage is a critical prognostic factor.

Purpose of the Study:

• To investigate the relationship between miR-21, PDCD4, and clinicopathological features in MTC.
• To assess the prognostic significance of the miR-21/PDCD4 pathway in MTC.
• To explore the role of the PI3K/Akt pathway in MTC.

Main Methods:

• Analysis of 64 MTC samples for RET and RAS mutations.
• Quantification of hsa-miR-21 using quantitative real-time polymerase chain reaction.
• Immunohistochemical analysis of PDCD4 and Ki-67, and immunoblotting for PI3K/Akt pathway proteins.

Main Results:

• MTCs showed consistent miR-21 upregulation and PDCD4 downregulation, inversely correlated (P = .0013).
• High miR-21 levels correlated with advanced stage, lymph node metastasis, and persistent disease.
• PDCD4 downregulation was associated with advanced stage and persistent disease; p-Akt was higher in RAS-mutated MTC.

Conclusions:

• The miR-21/PDCD4 pathway is dysregulated in MTC and correlates with prognostic variables.
• miR-21 may serve as a prognostic biomarker in MTC.
• Restoring PDCD4 function could be a potential therapeutic strategy for MTC.